Sastasundar Ventures Limited , a promoter group entity Luv Kush Projects Limited, has increased its stake in the company through a recent market purchase. The move underscores the promoter group's continued confidence in the company's prospects.

Transaction Details

The transaction, which took place on November 17, 2025, saw Luv Kush Projects Limited acquire 20,000 equity shares of Sastasundar Ventures Limited. This acquisition has resulted in an increase in their shareholding from 11.8993% to 11.9622% of the company's total equity.

Regulatory Compliance

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, Sastasundar Ventures Limited promptly disclosed this transaction to the stock exchanges. The company's Company Secretary and Compliance Officer, Pratap Singh, filed the necessary documentation on November 18, 2025.

Promoter Activity

It's worth noting that this transaction follows another recent share acquisition by a promoter of Sastasundar Ventures. On the same day, Banwari Lal Mittal, also a promoter of the company, acquired 20,000 equity shares worth Rs. 59,84,729.75. This increased Mittal's shareholding from 33.37% to 33.4355% of the company's capital.

Company Updates

In other company news, Sastasundar Ventures Limited recently hosted an Earnings Conference Call on November 17, 2025, discussing the company's performance for the quarter and half year ended September 30, 2025. The audio recording of this call has been made available on the company's website, providing transparency and accessibility for investors and analysts.

These recent developments, including the promoter group's increased stake and the company's proactive investor communication, may signal ongoing confidence in Sastasundar Ventures Limited's business strategy and future prospects. However, investors are advised to conduct their own research and consider market conditions before making investment decisions.

Sastasundar Ventures Limited , a key player in the healthcare network sector, has reported a significant reduction in its consolidated net loss for the second quarter of the fiscal year, despite an increase in revenue. The company's financial performance shows signs of improved operational efficiency, even as it continues to navigate challenges in the market.

Financial Highlights

Sastasundar Ventures reported a consolidated net loss of 127.00 million rupees in Q2, marking a substantial improvement from the 1.09 billion rupees loss recorded in the same period last year. This represents an 88% reduction in losses year-over-year, indicating the company's efforts towards financial stabilization are bearing fruit.

The company's quarterly revenue saw a notable increase, rising to 3.00 billion rupees from 2.73 billion rupees in the corresponding quarter of the previous year. This 9.9% growth in revenue suggests a strengthening market position and increased business activity.

Operational Performance

The improved financial results can be attributed to several factors:

1. Revenue Growth: The increase in revenue indicates a growing customer base and possibly an expansion of services or market reach.

2. Cost Management: The significant reduction in net loss, despite revenue growth, suggests effective cost control measures and improved operational efficiency.

3. Market Adaptation: The company appears to be adapting to market challenges, as evidenced by its ability to grow revenue while substantially reducing losses.

Future Outlook

While Sastasundar Ventures continues to operate at a loss, the substantial reduction in net loss coupled with revenue growth presents a positive trend. The company's focus on expanding its healthcare network and improving operational efficiency may contribute to further financial improvements in the coming quarters.

Investor Presentation Highlights

According to the recent investor presentation filed by the company:

• Sastasundar is expanding its operations beyond West Bengal to include NCR (National Capital Region), Jharkhand, and Assam.
• The company is focusing on product expansion in both B2B and B2C segments, including the launch of private label generic medicines and OTC products.
• Sastasundar is implementing a 'Quick Health Initiative' aimed at providing rapid healthcare services, including 10-minute doctor consultations and 30-minute medicine delivery.
• The company is strengthening its backend infrastructure with new fulfillment centers and strategic investments in health startups.
• There's an emphasis on AI integration across the value chain to improve efficiency and customer experience.

These strategic initiatives align with the company's efforts to drive growth and improve profitability in the long term.

As Sastasundar Ventures continues to evolve its business model and expand its healthcare network, investors and stakeholders will be watching closely to see if the positive trend in financial performance can be sustained in the coming quarters.